Hypocaloric diet supplemented with probiotic cheese improves body mass index and blood pressure indices of obese hypertensive patients - A randomized double-blind placebo-controlled pilot study

Nutrition Journal

Volumn 12, Issue 1, 2013, Pages

  Sharafedtinov, Khaider K ^a,b   Plotnikova, Oksana A ^a   Alexeeva, Ravilay I ^a   Sentsova, Tatjana B ^a   Songisepp, Epp ^c   Stsepetova, Jelena ^d   Smidt, Imbi ^d   Mikelsaar, Marika ^d  

^a FEDERAL RESEARCH CENTRE OF NUTRITION   (Russian Federation)

^b State Budgetary Inst of Cont Prof Education Russian Medical Academy of Postgraduate Education   (Russian Federation)

^c Tervisliku Piima Biotehnoloogiate Arenduskeskus   (Estonia)

^d UNIVERSITY OF TARTU   (Estonia)

Author keywords

Blood pressure; Body composition; Cholesterol; Fecal Lactobacilli; Hypocaloric diet; Lactobacillus plantarum TENSIA; Obesity; Plasma glucose; Plasma lipids; Probiotic cheese; Urine polyamines

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN; LIPID; LOW DENSITY LIPOPROTEIN; PLACEBO; PROBIOTIC AGENT; PUTRESCINE; SPERMIDINE; TRIACYLGLYCEROL; TYRAMINE;

ADULT; ARTERIAL PRESSURE; ARTICLE; BACTERIAL COLONIZATION; BLOOD PRESSURE; BODY COMPOSITION; BODY MASS; CHEESE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COMPARATIVE STUDY; CONSTIPATION; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; FAT MASS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; KIDNEY FUNCTION; LACTOBACILLUS PLANTARUM; LIPID BLOOD LEVEL; LIVER FUNCTION; LOW CALORY DIET; MALE; MUSCLE MASS; OBESITY; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; TOTAL BODY WATER; TRIACYLGLYCEROL BLOOD LEVEL; URINE LEVEL; WAIST HIP RATIO; WATER CONTENT;

LACTOBACILLUS PLANTARUM;

ADULT; ANTIHYPERTENSIVE AGENTS; BODY MASS INDEX; CHEESE; COMBINED MODALITY THERAPY; DIET, REDUCING; DOUBLE-BLIND METHOD; ESTONIA; FECES; FEMALE; HUMANS; HYPERTENSION; LACTOBACILLACEAE; LACTOBACILLUS PLANTARUM; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PILOT PROJECTS; PROBIOTICS; PUTRESCINE; WEIGHT LOSS;

EID: 84885360766     PISSN: None     EISSN: 14752891     Source Type: Journal    
DOI: 10.1186/1475-2891-12-138     Document Type: Article

References (56)

1. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr, Circulation 2009 120 1640 1645 10.1161/CIRCULATIONAHA.109.192644 19805654
2. Primary prevention of cardiovascular disease and type 2 diabetes in patients at metabolic risk: an endocrine society clinical practice guideline. Rosenzweig JL, Ferrannini E, Grundy SM, Haffner SM, Heine RJ, Horton ES, Kawamori R, J Clin Endocrinol Metab 2008 93 3671 3689 10.1210/jc.2008-0222 18664543
3. Dairy products and health: a review of the epidemiological evidence. Alvarez-Leon EE, Roman-Vinas B, Serra-Majem L, Br J Nutr 2006 96 Suppl 1 94 S99 16923261
4. A spread containing bioactive milk peptides Ile-Pro-Pro and Val-Pro-Pro, and plant sterols has antihypertensive and cholesterol-lowering effects. Turpeinen AM, Ikonen M, Kivimäki AS, Kautiainen H, Vapaatalo H, Korpela R, Food Funct 2012 3 621 627 10.1039/c2fo10286b 22398753
5. Inverse association between dairy intake and hypertension: the Rotterdam Study. Engberink MF, Hendriksen MA, Schouten EG, van Rooij FJ, Hofman A, Witteman JC, Geleijnse JM, Am J Clin Nutr 2009 89 1877 1883 10.3945/ajcn.2008. 27064 19369377
6. Potential uses of probiotics in clinical practice. Reid G, Jass J, Sebulsky MT, McCormick JK, Clin Microbiol Rev 2003 16 658 672 10.1128/CMR.16.4.658-672.2003 14557292 (Pubitemid 37296554)
7. Probiotics-a viable therapeutic alternative for enteric infections especially in the developing world. Sleator RD, Discov Med 2010 10 119 124 20807472
8. FAO/WHO, Guidelines for the evaluation of probiotics in food. Food and Agriculture Organization of the United Nations and World Health Organization Working Group Report London, Ontario, Canada 2002 Retrieved from: http://www.fao.org/es/ESN/Probio/probio.htm
9. Lactobacillus fermentum ME-3-an antimicrobial and antioxidative probiotic. Mikelsaar M, Zilmer M, Microb Ecol Health Dis 2009 21 1 27 10.1080/08910600902815561 19381356
10. Selection of potential probiotic lactobacilli for cholesterol-lowering properties and their effect on cholesterol metabolism in rats fed a high-lipid diet. Wang J, Zhang H, Chen X, Chen Y, Menghebilige, Bao Q, J Dairy Sci 2012 95 1645 1654 10.3168/jds.2011-4768 22459813
11. [Consumption of the probiotic Lactobacillus planctarum CECT 7315/7316 improves general health in the elderly subjects]. Bosch Gallego M, Espadaler Mazo J, Méndez Sánchez M, Pérez Carre M, Farrán Codina A, Audivert Brugué S, Bonachera Sierra MA, Cuñé Castellana J, Nutr Hosp 2011 26 642 645 21892586
12. Lactobacillus helveticus fermented milk lowers blood pressure in hypertensive subjects in 24-h ambulatory blood pressure measurement. Jauhiainen T, Vapaatalo H, Poussa T, Kyrönpalo S, Rasmussen M, Korpela R, Am J Hypertens 2005 18 1600 1605 10.1016/j.amjhyper.2005.06.006 16364832 (Pubitemid 41814682)
13. Design of a multispecies probiotic mixture to prevent infectious complications in critically ill patients. Timmerman HM, Niers LE, Ridwan BU, Koning CJ, Mulder L, Akkermans LM, Rombouts FM, Rijkers GT, Clin Nutr 2007 26 450 459 10.1016/j.clnu.2007.04.008 17544549 (Pubitemid 47091487)
14. Molecular and biochemical characterizations of human oral lactobacilli as putative probiotic candidates. Strahinic I, Busarcevic M, Pavlica D, Milasin J, Golic N, Topisirovic L, Oral Microbiol Immunol 2007 22 111 117 10.1111/j.1399-302X.2007.00331.x 17311634
15. Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero- and uropathogens. Hutt P, Shchepetova J, Loivukene K, Kullisaar T, Mikelsaar M, J Appl Microbiol 2006 100 1324 1332 10.1111/j.1365-2672.2006. 02857.x 16696680 (Pubitemid 43725697)
16. Probiotic properties of Lactobacillus rhamnosus and Lactobacillus paracasei isolated from human faeces. Verdenelli MC, Ghelfi F, Silvi S, Orpianesi C, Cecchini C, Cresci A, Eur J Nutr 2009 48 355 363 10.1007/s00394-009-0021-2 19365593
17. Effect of Lactobacillus plantarum 299v on cardiovascular disease risk factors in smokers. Naruszewicz M, Johansson ML, Zapolska-Downar D, Bukowska H, Am J Clin Nutr 2002 76 1249 1255 12450890 (Pubitemid 35416559)
18. Probiotics and immunosenescence: cheese as a carrier. Ibrahim F, Ruvio S, Granlund L, Salminen S, Viitanen M, Ouwehand AC, FEMS Immunol Med Microbiol 2010 59 53 59 10.1111/j.1574-695X.2010.00658.x 20236323
19. Intestinal Lactobacilli of Estonian and Swedish Children. Mikelsaar M, Annuk H, Shchepetova J, Mandar R, Sepp E, Bjorksten B, Microbial Ecol Health Dis 2002 14 75 80 10.1080/08910600260081711 (Pubitemid 34832420)
20. Songisepp E, Mikelsaar M, Ratsep M, Zilmer M, Hutt P, Utt M, Zilmer K, Oksti J, Koljalg S, Inventors, Isolated microorganism strain Lactobacillus plantarumTENSIA DSM 21380 antimicrobial and antihypertensive probiotic, food product and composition comprising said microorganism and use of said microorganism for preparation of antihypertensive medicine and method for suppressing pathogens and nonstarter lactobacilli in food product Bio-Competence Centre of Healthy Dairy Products LLC, assignee In pat appl WO2009138091. 2009
21. Characterization of oral lactobacilli as potential probiotics for oral health. Koll P, Mandar R, Marcotte H, Leibur E, Mikelsaar M, Hammarstrom L, Oral Microbiol Immunol 2008 23 139 147 10.1111/j.1399-302X.2007.00402.x 18279182 (Pubitemid 351248609)
22. Safety of a probiotic cheese containing Lactobacillus plantarum Tensia according to a variety of health indices in different age groups. Songisepp E, Hütt P, Rätsep M, Shkut E, Kõljalg S, Truusalu K, Stsepetova J, Smidt I, Kolk H, Zagura M, Mikelsaar M, J Dairy Sci 2012 95 5495 5509 10.3168/jds.2011-4756 22863096
23. The Nordic Reference Interval Project 2000: recommended reference intervals for 25 common biochemical properties. Rustad P, Felding P, Franzson L, Kairisto V, Lahti A, Martensson A, Hyltoft Petersen P, Simonsson P, Steensland H, Uldall A, Scand J Clin Lab Invest 2004 64 271 284 10.1080/00365510410006324 15223694 (Pubitemid 38918099)
24. Analysis of biogenic amines by GC/FID and GC/MS. Thesis Virginia Polytechnic Institute. Nakovich L, 2003 URL http://scholar.lib.vt.edu/theses/ available/etd-09122003-131120/unrestricted/LN-Thesis.pdf
25. Burtis CA, Ashwood ER, Bruns D, Tietz Textbook of Clinical Chemistry Philadelphia, PA: WB Saunders Company 4 1998
26. Characterization of bacterial communities in feces from healthy elderly volunteers and hospitalized elderly patients by using real-time PCR and effects of antibiotic treatment on the fecal microbiota. Bartosch S, Fite A, Macfarlane GT, McMurdo ME, Appl Environ Microbiol 2004 70 3575 3581 10.1128/AEM.70.6.3575- 3581.2004 15184159 (Pubitemid 38745906)
27. Management of metabolic syndrome through probiotic and prebiotic interventions.Indian J. Mallappa RH, Rokana N, Duary RK, Panwar H, Batish VK, Grover S, Endocrinol Metab 2012 16 20 27
28. Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial. Kadooka Y, Sato M, Imaizumi K, Ogawa A, Ikuyama K, Akai Y, Okano M, Kagoshima M, Tsuchida T, Eur J Clin Nutr 2010 64 636 643 10.1038/ejcn.2010.19 20216555
29. Diversity and metabolic impact of intestinal Lactobacillus species in healthy adults and the elderly. Štšepetova J, Sepp E, Kolk H, Lõivukene K, Songisepp E, Mikelsaar M, Br J Nutr 2011 105 1235 1244 10.1017/S0007114510004770 21303568
30. Changes in the gut microbiota of cloned and non-cloned control pigs during development of obesity: gut microbiota during development of obesity in cloned pigs. Pedersen R, Andersen AD, Mølbak L, Stagsted J, Boye M, BMC Microbiol 2013 13 30 10.1186/1471-2180-13-30 23391125
31. Probiotics in foods not containing milk or milk constituents, with special reference to Lactobacillus plantarum 299v. Molin G, Am J Clin Nutr 2001 73 380S 385S 11157345 (Pubitemid 32113259)
32. The normal Lactobacillus flora of healthy human rectal and oral mucosa. Ahrné S, Nobaek S, Jeppsson B, Adlerberth I, Wold AE, Molin G, J Appl Microbiol 1998 85 88 94 10.1046/j.1365-2672.1998.00480.x 9721659 (Pubitemid 28363983)
33. Complete genome sequence of Lactobacillus plantarum WCFS1. Kleerebezem M, Boekhorst J, van Kranenburg R, Molenaar D, Kuipers OP, Leer R, Tarchini R, Peters SA, Sandbrink HM, Fiers MW, et al. Proc Natl Acad Sci U S A 2003 100 1990 1995 10.1073/pnas.0337704100 12566566 (Pubitemid 36254561)
34. PCR and RAPD identification of L. plantarum strains isolated from ovine milk and cheese. Geographical distribution of strains. Oneca M, Irigoyen A, Ortigosa M, Torre P, FEMS Microbiol Lett 2003 227 271 277 10.1016/S0378-1097(03) 00691-8 14592719 (Pubitemid 37329887)
35. Order II. Lactobacillales ord. nov. Ludwig W, Scheifer KH, Whitman WB, Bergey's Manual of Systematic Bacteriology, Volume 3 New York: Springer, Whitman WB, 2 2009 463 513
36. Probiotic properties of Lactobacillus plantarum CECT 7315 and CECT 7316 isolated from faeces of healthy children. Bosch M, Rodriguez M, Garcia F, Fernández E, Fuentes MC, Cuñé J, Lett Appl Microbiol 2012 54 240 246 10.1111/j.1472-765X.2011.03199.x 22188552
37. Cholesterol-lowering efficacy of Lactobacillus plantarum CECT 7527, 7528 and 7529 in hypercholesterolaemic adults. Fuentes MC, Lajo T, Carrion JM, Cune J, Br J Nutr 2013 109 1866 1872 10.1017/S000711451200373X 23017585
38. Persistence of Lactobacillus reuteri DSM17938 in the human intestinal tract: response to consecutive and alternate-day supplementation. Smith TJ, Anderson D, Margolis LM, Sikes A, Young AJ, J Am Coll Nutr 2011 30 259 264 10.1080/07315724.2011.10719968 21917706
39. The impact of a consortium of fermented milk strains on the gut microbiome of gnotobiotic mice and monozygotic twins. McNulty NP, Yatsunenko T, Hsiao A, Faith JJ, Muegge BD, Goodman AL, Henrissat B, Oozeer R, Cools Portier S, Gobert G, et al. Sci Transl Med 2011 3 106ra106 10.1126/scitranslmed.3002701 22030749
40. Intestinal Lactobacillus sp. is associated with some cellular and metabolic characteristics of blood in elderly people. Mikelsaar M, Stsepetova J, Hutt P, Kolk H, Sepp E, Loivukene K, Zilmer K, Zilmer M, Anaerobe 2010 16 240 246 10.1016/j.anaerobe.2010.03.001 20223288
41. A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects. Hata Y, Yamamoto M, Ohni M, Nakajima K, Nakamura Y, Takano T, Am J Clin Nutr 1996 64 767 771 8901799 (Pubitemid 26398281)
42. A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects. Seppo L, Jauhiainen T, Poussa T, Korpela R, Am J Clin Nutr 2003 77 326 330 12540390 (Pubitemid 36133373)
43. Angiotensin I-converting-enzyme-inhibitory and antibacterial peptides from Lactobacillus helveticus PR4 proteinase-hydrolyzed caseins of milk from six species. Minervini F, Algaron F, Rizzello CG, Fox PF, Monnet V, Gobbetti M, Appl Environ Microbiol 2003 69 5297 5305 10.1128/AEM.69.9.5297-5305.2003 12957917 (Pubitemid 37150754)
44. Angiotensin-converting enzyme and its clinical significance-a review. Studdy PR, Lapworth R, Bird R, J Clin Pathol 1983 36 938 947 10.1136/jcp.36.8.938 6308066 (Pubitemid 13030613)
45. Casein fermentate of Lactobacillus animalis DPC6134 contains a range of novel propeptide angiotensin-converting enzyme inhibitors. Hayes M, Stanton C, Slattery H, O'Sullivan O, Hill C, Fitzgerald GF, Ross RP, Appl Environ Microbiol 2007 73 4658 4667 10.1128/AEM.00096-07 17483275 (Pubitemid 47122611)
46. Reactive oxygen species and vascular biology: implications in human hypertension. Touyz RM, Briones AM, Hypertens Res 2011 34 5 14 10.1038/hr.2010.201 20981034
47. ER stress in the brain subfornical organ mediates angiotensin-dependent hypertension. Young CN, Cao X, Guruju MR, Pierce JP, Morgan DA, Wang G, Iadecola C, Mark AL, Davisson RL, J Clin Invest 2012 122 3960 3964 10.1172/JCI64583 23064361
48. Influence of the polyamine, spermidine, on intestinal maturation and dietary antigen uptake in the neonatal rat. Capano G, Bloch KJ, Schiffrin EJ, Dascoli JA, Israel EJ, Harmatz PR, J Pediatr Gastroenterol Nutr 1994 19 34 42 10.1097/00005176-199407000-00006 7965474 (Pubitemid 24243182)
49. Fasting and postprandial polyamine concentrations in the human digestive lumen. Benamouzig R, Mahe S, Luengo C, Rautureau J, Tome D, Am J Clin Nutr 1997 65 766 770 9062527 (Pubitemid 27111083)
50. Role of polyamines in gastrointestinal mucosal growth. McCormack SA, Johnson LR, Am J Physiol 1991 260 795 806 2058669
51. Polyamines: metabolism and implications in human diseases. Moinard C, Cynober L, de Bandt JP, Clin Nutr 2005 24 184 197 10.1016/j.clnu.2004.11.001 15784477 (Pubitemid 40392801)
52. Acetylpolyamines decrease blood pressure, [Ca++]i and isometric force of vascular smooth muscle. Wing LY, Chan CF, Jiang MJ, J Pharmacol Exp Ther 1993 266 179 183 8331557
53. Effect of dietary protein supplementation on blood pressure: a randomized, controlled trial. He J, Wofford MR, Reynolds K, Chen J, Chen CS, Myers L, Minor DL, Elmer PJ, Jones DW, Whelton PK, Circulation 2011 124 589 595 10.1161/CIRCULATIONAHA.110.009159 21768541
54. Protein and amino acid metabolism in uremia: influence of metabolic acidosis. Mitch WE, May RC, Maroni BJ, Druml W, Kidney Int Suppl 1989 27 205 207 2636659
55. Mechanisms for protein catabolism in uremia: metabolic acidosis and activation of proteolytic pathways. Greiber S, Mitch WE, Miner Electrolyte Metab 1992 18 233 236 1465065
56. Metabolic surgery profoundly influences gut microbial-host metabolic cross-talk. Li JV, Ashrafian H, Bueter M, Kinross J, Sands C, le Roux CW, Bloom SR, Darzi A, Athanasiou T, Marchesi JR, et al. Gut 2011 60 1214 1223 10.1136/gut.2010.234708 21572120